Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma

BMC Gastroenterology

Volumn 5, Issue , 2005, Pages

  Bergheim, Ina ^a,b   Bode, Christiane ^a   Parlesak, Alexandr ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; MESSENGER RNA; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYP3A5 PROTEIN, HUMAN; CYTOCHROME P 450 CYP2C SUBFAMILY; CYTOCHROME P-450 CYP2C SUBFAMILY; CYTOCHROME P450; CYTOCHROME P450 3A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLON BIOPSY; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WESTERN BLOTTING; ADENOMA; CASE CONTROL STUDY; COLON; COLON TUMOR; ENZYMOLOGY; GENETICS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; OSMOLARITY; TISSUE DISTRIBUTION;

ADENOMA; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COLON; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INTESTINAL MUCOSA; MIDDLE AGED; OSMOLAR CONCENTRATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 27944453621     PISSN: 1471230X     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-5-34     Document Type: Article

References (27)

1. Sheweita, S A: Drug-metabolizing enzymes: mechanisms and functions. Curr. Drug Metab 2000, 1:107-132
2. Oyama, T, Kagawa, N, Kunugita, N, Kitagawa, K, Ogawa, M, Yamaguchi, T, Suzuki, R, Kinaga, T, Yashima, Y, Ozaki, S, Isse, T, Kim, Y D, Kim, H, and Kawamoto, T: Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci. 2004, 9:1967-1976
3. Ding, X, Kaminsky, L S: Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 2003, 43:149-173
4. Kaminsky, L S, Fasco, M J: Small intestinal cytochromes P450. Crit Rev. Toxicol. 1991, 21:407-422
5. Zhang, Q Y, Dunbar, D, Ostrowska, A, Zeisloft, S, Yang, J, Kaminsky, L S: Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos. 1999, 27:804-809.
6. Peters, W H, Kock, L, Nagengast, F M, Kremers, P G: Biotransformation enzymes in human intestine: critical low levels in the colon? Gut 1991, 32:408-412
7. Kolars, J C, Lown, K S, Schmiedlin-Ren, P, Ghosh, M, Fang, C, Wrighton, S A, Merion, R M, Watkins, P B: CYP3A gene expression in human gut epithelium. Pharmacogenetics. 1994, 4:247-259
8. Chun, Y J, Lee, S, Yang, S A, Park, S, Kim, M Y: Modulation of CYP3A4 expression by ceramide in human colon carcinoma HT-29 cells. Biochem. Biophys. Res. Commun. 2002, 298:687-692
9. Pfrunder, A, Gutmann, H, Beglinger, C, Drewe, J: Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. J. Pharm. Pharmacol. 2003, 55:59-66
10. White, T B, Hammond, D K, Vásquez, H, Strobel, H W: Expression of two cytochromes P450 involved in carcinogen activation in a human cell line. Mol. Cell. Biochem. 1991, 102:61-69
11. Hakkak, R, Korourian, S, Ronis, M J, Ingelman-Sundberg, M, Badger, T M: Effects of diet and ethanol on the expression and localization of cytochromes P450 2E1 and P450 2C7 in the colon of male rats. Biochem. Pharmacol. 1996, 51:61-69
12. Massaad, L, de Waziers, I, Ridbrag, V, Janot, F, Beaune, P H, Morizet, J, Gouyette, A, Chabot, G G: Comparison of Mouse and Human Colon Tumors with Regard to Phase I and Phase II Drug-metabolizing Enzyme Systems. Cancer Research 1992, 52:6567-6575
13. Massaad, L, Chabot, G G, Toussaint, C, Koscielny, S, Morizet, J, Bissery, M C, Gouyette, A: Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38. Cancer Chemother. Pharmacol. 1994, 34:497-502
14. Yokose, T, Doy, M, Taniguchi, T, Shimada, T, Kakiki, M, Horie, T, Matsuzaki, Y, Mukai, K: Immunohistochemical study of cytochrome P450 2C and 3A in human non-neoplastic and neoplastic tissues. Virchows Arch. 1999, 434:401-411
15. Bradford, M M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254
16. Agundez, J A: Cytochrome P450 gene polymorphism and cancer. Curr. Drug Metab 2004. 2004,5:211-224
17. McKay, J A, Murray, G I, Weaver, R J, Ewen, S W, Melvin, W T, Burke, M D: Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut 1993, 34:1234-1239
18. De Waziers, I, Cugnenc, P H, Berger, A, Leroux, J P, Beaune, P H: Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samples. Carcinogenesis 1991, 12:905-909
19. McKinnon, R A, Burgess, W M, Gonzalez, F J, McManus, M E: Metabolic differences in colon mucosal cells. Mutat. Res. 1993, 290:27-33
20. Mercurio, M G, Shiff, S J, Galbraith, R A, Sassa, S: Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjects. Biochem. Biophys. Res. Commun. 1995, 210:350-355
21. Eliasson, E, Mkrtchian, S, Ingelman-Sundberg, M: Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J. Biol. Chem. 1992, 267:15765-15769
22. Feierman, D E, Melnikov, Z, Zhang, J: The paradoxical effect of acetaminophen on CYP3A4 activity and content in transfected HepG2 cells. Arch. Biochem. Biophys. 2002, 398:109-117
23. Zangar, R C, Hernandez, M, Novak, R F: Posttranscriptional elevation of cytochrome P450 3A expression. Biochem. Biophys. Res. Commun. 1997, 231:203-205
24. Kocarek, T A, Zangar, R C, and Novak, R F: Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch. Biochem. Biophys. 2000, 376:180-190
25. Futscher, B W, Blake, L L, Gerlach, J H, Grogan, T M, Dalton, W S: Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal. Biochem. 1993, 213:414-421
26. Hakkola, J, Pasanen, M, Purkunen, R, Saarikoski, S, Pelkonen, O, Maenpaa, J, Rane, A, Raunio, H: Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem. Pharmacol. 1994, 48:59-64
27. Kivisto, K T, Griese, E U, Fritz, P, Linder, A, Hakkola, J, Raunio, H, Beaune, P, Kroemer, H K: Expression of cytochrome P 450 3A enzymes in human lung: a combined RT- PCR and immunohistochemical analysis of normal tissue and lung tumours. Naunyn Schmiedebergs Arch. Pharmacol. 1996, 353:207-212